Takeda Pharmaceutical
TAK
#412
Rank
S$73.39 B
Marketcap
S$23.23
Share price
0.77%
Change (1 day)
18.93%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): S$4.19 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are S$29.86 Billion. , an increase over its 2024 earnings that were of S$2.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 S$4.24 B49.03%
2024 S$2.84 B-2.41%
2023 S$2.91 B-28.14%
2022 S$4.05 B-40.9%
2021 S$6.86 B78.24%
2020 S$3.85 B246.1%
2019 S$1.11 B-48.79%
2018 S$2.17 B-23.64%
2017 S$2.84 B21.7%
2016 S$2.33 B-253.01%
2015 -S$1.53 Billion-159.65%
2014 S$2.56 B13%
2013 S$2.26 B2.46%
2012 S$2.21 B-57.05%
2011 S$5.15 B-10.49%
2010 S$5.75 B-3.99%
2009 S$5.99 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.30 B 874.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.84 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$15.11 B 256.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.51 B 147.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.60 B 173.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$29.44 B 594.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.88 B 180.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-S$1.01 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$1.11 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India